Skip to main content

Most Popular

lupus.nephritis.immunofluorescence.jpg

Serologically Active, Clinically Quiescent SLE

Nov 01, 2021

Lupus management is guided by assessment of both clinical and serologic features; but what happens with the patient with systemic lupus erythematosus (SLE) serologically active, but clinically quiescent (SACQ)?  A large cohort study shows that nearly one-third of such patients may flare and may r

Read Article
guidelines.recommendations.jpg

Management of Immune-Related Adverse Events - ASCO Guideline

Nov 02, 2021

The American Society of Clinical Oncology, Inc (ASCO) has updated its guidelines and recommendations for the management of immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitor (ICPi) therapy.

Read Article
ACR Best

ACR21 Best Abstracts - Day 1

Nov 07, 2021

The RheumNow faculty have been glued to their monitors all day, watching video, and running down abstract presentations to find the best – several of these stood out as #ACRBests. Here is a listing of “Best” they saw on Day 1.

Read Article
PSA2L.jpg

An Old Friend – Methotrexate in Psoriatic Arthritis

Nov 16, 2021

Methotrexate (MTX) remains one of our most used and reliable tools against a variety of rheumatic diseases, particularly in the care of peripheral arthritis such as psoriatic arthritis (PsA).

Read Article
RheumNow Podcast square

RheumNow Podcast – Like Father, Like Daughter (10.29.2021)

Oct 29, 2021

Dr. Jack Cush reviews the news and journal articles from the past week and discusses parent-child rheumatologists pairs.

Read Article
Giant-Cell_Vasculitis.jpg

Top vasculitis takeaways from ACR 2021

There were several hot topics and it is difficult to give all the top abstracts, so I will concentrate on vasculitis. 

Giant cell arteritis

Read Article
RheumNow Podcast square

RheumNow Podcast - ACR 2021 Rehash (the good stuff..)

Nov 12, 2021

The ACR 2021 meeting has concluded. Dr. Jack Cush recounts a few more great abstracts from this past week’s virtual meeting.

Abstract Numbers below:

Psoriatic arthritis

Read Article
Cush ACR learning computer online

Day 2 Report from ACR21

Nov 08, 2021

Highlight reports from Sunday, Day 2 at ACR Convergence included:

VITAL Trial: Vitamin D and n-3 Fatty Acid Supplements Protect Against Autoimmune Disease

Read Article
meeting.audience.3_0.jpg

Day 1 Report from ACR21

Nov 07, 2021

The first full day of Abstracts and Presentations from ACR Convergence, the 2021 Virtual meeting, was full of highly engaging sessions, quality posters and unique presentations.  To hear more about the best of the best, I would encourage you to look at our

Read Article
Conway still

GLORIA Study - Is Prednisone Harmful in Elder RA?

Nov 17, 2021

The GLORIA study (ABST# 1678) was a pragmatic, blinded placebo-controlled randomized trial from Dr. Martin Boers and colleagues where they assessed whether prednisolone (vs. placebo) use would alter clinical outcomes over 2 years.

Read Article
ACR Best

ACR21 Best Abstracts We Saw - Day 3 (Monday)

Nov 08, 2021

The third day of ACR 2021 took a big leap in online content.  Here is a compilation (with links) of presentations were the “ACRBest” as seen by our RheumNow faculty. 

Read Article
ACR Best

ACR21 Best Abstracts - Day 4

Nov 10, 2021

On the last day of ACR21 Annual Meeting, the RheumNow faculty selected these as their favorite reports:

Read Article
SI AS SpA ACR

TNF inhibitors and radiographic progression in axSpA

Nov 07, 2021

A remaining challenge for clinicians is the ability to delay, if not completely stop, structural progression in patients with axial spondyloarthritis (ax-Spa), whether they are diagnosed with radiographic (r-axSpa) or non-radiographic (nr-axSpA) disease.

Read Article
acr_session2.jpeg

Opening Day Report

Nov 06, 2021

The opening of ACR2 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and interview with Dr. Seema Yasmin (Stanford).

Read Article
uveitis eye iritis

New Insights into Uveitis in Spondyloarthritis

Nov 09, 2021

Uveitis is the most frequent extra-musculoskeletal manifestation (EAM) in Axial Spondyloarthritis (axSpA). The prevalence of uveitis in axSpA is between 25-30%. Up to 50% of patients with an acute episode of uveitis develop recurrent anterior uveitis or iritis.

Read Article
EULAR19.abstract.jpg (keep)

ACR21 – Day 3 Report

Nov 09, 2021

Hitting the home stretch, day 3 presentations were big! Here are a few of my favorites:

Secukinumab Efficacy in Enthesitis-Related and Juvenile Psoriatic Arthritis.

Read Article
audience learn

Day 4 Report from ACR21

Nov 10, 2021

My favorite three presentations from day 4 at ACR 2021 included the following:

Breakthrough Infections in Rheumatic Disease Patients

Read Article
PSO.Palmoplantar.jpg

Biologic Use and the Risk of Serious Infection in Psoriasis Patients

Oct 28, 2021

National Health Data from France examined biologic use in patients with moderate to severe psoriasis, and found the risk of serious infections (SIE) to be increased with some biologics (infliximab and adalimumab), but not others (etanercept, ustekinumab IL-17 and IL-23 inhibitors or apremilast). 

Read Article
iv.infusion.jpg

Can "Ultra-low" dose Rituximab work for RA?

Nov 11, 2021

At day 3 of ACR Convergence 2021, the REDO trial presented data in abstract 1443 in an oral presentation challenging how low we can go with rituximab for rheumatoid art

Read Article
×